当前位置: X-MOL 学术Clin. Cancer Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Not Yet Another Negative Trial-ReACTing on Recent Glioblastoma Trials!
Clinical Cancer Research ( IF 11.5 ) Pub Date : 2020-04-01 , DOI: 10.1158/1078-0432.ccr-19-4032
Wolfgang Wick 1 , Robin J Wagener 1
Affiliation  

The present ReACT trial provides data from a small randomized controlled vaccination trial that in addition to other recent immunotherapy trials in glioblastoma allows sketching a rational, advanced trial design for the development of (immune) therapies in glioblastoma elaborating on but not restricting to biological monitoring and endpoints.See related article by Reardon et al., p. XXX.

中文翻译:

近期胶质母细胞瘤试验还不是另一个阴性试验!

本ReACT试验提供的数据来自一个小型的随机对照疫苗接种试验,该试验除了最近在胶质母细胞瘤中进行的其他免疫治疗试验外,还可以为胶质母细胞瘤的(免疫)疗法的发展制定合理,先进的试验设计,该试验的设计是但不限于生物学监测和端点,请参见Reardon等人的相关文章,第1页。XXX。
更新日期:2020-04-01
down
wechat
bug